Developing new treatments to combat bacterial resistance using biopharmaceuticals
Preclinical Services for Antibacterial Resistance Biopharmaceutical Product Development
['FUNDING_OTHER'] · AMERICAN TYPE CULTURE COLLECTION · NIH-10934750
This study is working on new treatments to help fight infections caused by bacteria that don't respond to regular medicines, and it aims to create better therapies for patients who need them.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | AMERICAN TYPE CULTURE COLLECTION (nih funded) |
| Locations | 1 site (MANASSAS, UNITED STATES) |
| Trial ID | NIH-10934750 on ClinicalTrials.gov |
What this research studies
This research focuses on the preclinical development of innovative biopharmaceutical products aimed at addressing bacterial drug resistance. It utilizes advanced biotechnology processes to create materials such as monoclonal antibodies, recombinant proteins, and small interfering RNA (siRNA) vectors. The program includes comprehensive services like product development planning, assay development, and regulatory support to ensure effective translation of these products into clinical applications for infectious diseases. Patients may benefit from new therapies that emerge from this research as it progresses through the development pipeline.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals suffering from infections that are resistant to current antibiotic treatments.
Not a fit: Patients with infections that are not caused by bacterial pathogens or those who do not have antibiotic-resistant infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and effective treatments for infections caused by antibiotic-resistant bacteria.
How similar studies have performed: Other research in the field of biopharmaceuticals has shown promise in developing effective treatments for bacterial resistance, indicating that this approach has potential for success.
Where this research is happening
MANASSAS, UNITED STATES
- AMERICAN TYPE CULTURE COLLECTION — MANASSAS, UNITED STATES (ACTIVE)
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Infectious Diseases Research, Infectious Diseases / Laboratory